• Mashup Score: 2
    Program Guide – ASCO Meeting Program Guide - 1 year(s) ago

    ASCO-SEP 2022 Digital SubscriptionA comprehensive program for your self-assessment needs includes all-digital SEP® content (22 chapters + more chapter questions), an updated Question Bank, and additional educational resources. Subscribe today!

    Source: meetings.asco.org
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCO
      ASCO

      Did you miss yesterday's #ASCOPlenarySeries session highlighting treatment for KRASG12C mutation & resectable #NSCLC? Catch up here ➡️ https://t.co/LaL38YG9zS #gicsm #lcsm #OncTwitter @OncoAlert https://t.co/TBLHzCijAW

  • Mashup Score: 2
    ASCO Plenary Series Program - 1 year(s) ago

    Learn more about the faculty and program for the April Plenary Series session.

    Source: ASCO
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCO
      ASCO

      Today @ 3 PM ET‼️ #ASCOPlenarySeries will highlight tx for lung and GI cancers 🔹Interim EFS analysis of ph3 Neotorch: Periop toripalimab + platinum-doublet chemo for #NSCLC 🔹KRYSTAL-1: Adagrasib in adv solid tumors w KRASG12C mutation 🔗: https://t.co/hwiQgZl9hl @OncoAlert https://t.co/9ZXgT8JVxK

  • Mashup Score: 2
    Program Guide – ASCO Meeting Program Guide - 1 year(s) ago

    AuthorsShun LuShanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, ChinaShun Lu, Lin Wu, Wei Zhang, Peng Zhang, Wenxiang Wang, Wentao Fang, Wenqun Xing, Qixun Chen, Jiandong Mei, Lin Yang, Lijie Tan, Xiaohong Sun, Shidong Xu, Xiaohua Hu, Guohua Yu, Dongliang Yu, Jinlu Shan, Nong Yang, Yuping Chen, Hui TianOrganizationsShanghai Lung Cancer Center, Shanghai…

    Source: meetings.asco.org
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCO
      ASCO

      Latest from #ASCOPlenarySeries: Adding Toripalimab to Chemo Improves Event-Free Survival in Patients w/ Resectable #NSCLC Tune in to the live presentation, expert discussion and Q&A tomorrow, 4/20, @ 3 PM ET! Abstract ➡️ https://t.co/mTlGUysgdW #lcsm @oncoalert @MLJohnsonMD2 https://t.co/4RIDodjpzh

  • Mashup Score: 4
    Program Guide – ASCO Meeting Program Guide - 1 year(s) ago

    AuthorsShubham PantThe University of Texas MD Anderson Cancer Center, Houston, TXShubham Pant, Rona Yaeger, Alexander I. Spira, Meredith Pelster, Joshua K. Sabari, Navid Hafez, Minal A. Barve, Karen Velastegui, xiaohong yan, Hirak Der-Torossian, Tanios S. Bekaii-SaabOrganizationsThe University of Texas MD Anderson Cancer Center, Houston, TX, Department of Medicine, Memorial Sloan Kettering Cancer…

    Source: meetings.asco.org
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCO
      ASCO

      Latest from #ASCOPlenarySeries: Adagrasib Shows Promising Activity in KRASG12C Mutated Cancers Tune in to the live presentation, expert discussion and Q&A tomorrow, 4/20, @ 3 PM ET! Abstract ➡️ https://t.co/HHpWuTWNlO @DrChoueiri @DrShubhamPant @ElenaGarralda @OncoAlert https://t.co/R4a3Qec2ac

  • Mashup Score: 9
    ASCO Plenary Series Program - 1 year(s) ago

    Learn more about the faculty and program for the April Plenary Series session.

    Source: ASCO
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCO
      ASCO

      #ASCOPlenarySeries to highlight tx for lung, GI cancers 🔹Interim EFS analysis of ph3 Neotorch: Periop toripalimab + platinum-doublet chemo for #NSCLC 🔹KRYSTAL-1: Adagrasib in adv solid tumors w KRASG12C mutation Tune in Thurs @ 3 PM ET ➡️ https://t.co/RxUyseNqdE @OncoAlert https://t.co/Fi5sb6OIQX

  • Mashup Score: 7
    ASCO Plenary Series Program - 1 year(s) ago

    Learn more about the faculty and program for the April Plenary Series session.

    Source: ASCO
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCO
      ASCO

      April #ASCOPlenarySeries to highlight: ⭐ Interim EFS analysis of ph3 Neotorch: Perioperative toripalimab + platinum-doublet chemo for #NSCLC ⭐ KRYSTAL-1: Adagrasib in adv solid tumors w KRASG12C mutation 📅 Live presentation 4/20 @ 3 PM ET Details: https://t.co/DQOZADGB8p https://t.co/ADkeFfY9kN

  • Mashup Score: 2
    Program Guide – ASCO Meeting Program Guide - 1 year(s) ago

    You must be logged in and have a current registration to access this session’s video and slides. If you think you should have access, please Sign In . If not, you can still get access via a purchase. This material on this page is ©2023 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

    Source: meetings.asco.org
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCO
      ASCO

      Did you miss yesterday's #ASCOPlenarySeries session highlighting the Phase 3 GLOW results of zolbetuximab + CAPOX in CLDN18.2+/HER2− locally advanced mG/GEJ adenocarcinoma? Catch up here ➡️ https://t.co/ZNVe5xFUjk @OncoAlert @mdmanishshah @YJanjigianMD #STCSM #ESOCSM https://t.co/Jr5vY50f6C

  • Mashup Score: 7
    ASCO Plenary Series Program - 1 year(s) ago

    Learn more about the faculty and program for the March Plenary Series session.

    Source: ASCO
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCO
      ASCO

      ‼️ #ASCOPlenarySeries: Zolbetuximab + CAPOX improves survival in patients with CLDN18.2+/HER2− LA mG/GEJ adenocarcinoma Tune in to the live presentation, expert discussion and Q&A TODAY @ 4 PM ET ➡️ https://t.co/2bse8Dwkjt @OncoAlert @mdmanishshah @yjanjigianMD #STCSM #ESOCSM https://t.co/Ati8CAYD2l

  • Mashup Score: 0
    Program Guide – ASCO Meeting Program Guide - 1 year(s) ago

    AuthorsRui-hua XuState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, ChinaRui-hua Xu, Kohei Shitara, Jaffer A. Ajani, Yung-Jue Bang, Peter C. Enzinger, David H. Ilson, Florian Lordick, Eric Van Cutsem, Javier Gallego Plazas, Jing Huang, Lin Shen, Sang Cheul Oh, Patrapim…

    Source: meetings.asco.org
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCO
      ASCO

      #ASCOPlenarySeries to highlight Zolbetuximab + CAPOX in CLDN18.2+/HER2− LA mG/GEJ adenocarcinoma: Primary ph3 results from GLOW 📅 Live presentation 3/22 @ 4 PM ET Panel: Drs. E. Gabriela Chiorean @mdmanishshah @yjanjigianMD Abstract ➡️ https://t.co/jkFMBk22mW #STCSM #ESOCSM https://t.co/EPptpFCUEv

Load More